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Abstract
Background: To investigate if age, gender and smoking are associated with airway wall thickness (AWT) measured
by high resolution computed tomography (HRCT) and if higher AWT is associated with lower levels of pulmonary
function in healthy current- and never-smokers with a wide age range.
Methods: HRCT scans were performed in 99 subjects (48 never- and 51 current-smokers, median age 39 years
[IQR 22 – 54], 57% males). The AWT at an internal perimeter of 10 mm (AWT Pi10) was calculated as an overall
measurement of AWT, based on all measurements throughout the lungs. Extensive pulmonary function testing
was performed in all subjects.
Results: Higher age was associated with a lower AWT Pi10 (b = −0.003, p < 0.001). Current-smokers had a higher AWT
Pi10 than never-smokers (mean 0.49 mm versus 0.44 mm, p = 0.022). In multivariate analysis, age and current-smoking
were independently associated with AWT Pi10 (age b = −0.002, p < 0.001, current-smoking b = 0.041, p = 0.021),
whereas gender was not (b = 0.011, p = 0.552). Higher AWT Pi10 was associated with a lower FEV1, FEV1/FVC,
FEF25–75 and higher R5, R20 and X5.
Conclusions: AWT decreases with higher age, possibly reflecting structural changes of the airways. Additionally,
current-smokers have a higher AWT, possibly due to remodeling or inflammation. Finally, higher AWT is associated
with a lower level of pulmonary function, even in this population of healthy subjects.
Trial registration: This Study was registered at www.clinicaltrials.gov with number NCT00848406 on 19 February 2009.
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Background
Chronic inflammatory processes in the airways, like those
occurring in asthma and chronic obstructive pulmonary
disease (COPD), induce airway remodeling. This is
associated with changes in the epithelial layer, reticular
basement membrane and smooth muscle, all contributing
to thickening of the airway walls [1, 2].
Computed tomography (CT) can be used as a non-
invasive tool to assess airway wall thickness (AWT).
Using this technique, it has been shown that the airways
walls of patients with COPD are significantly thicker
than those of healthy non-smoking controls [3]. In
addition, it has been shown that higher AWT is associated
with more severe airflow obstruction in COPD [3–10].
Although these studies provided important insights, there
were also some drawbacks. Most studies performed thus
far used transverse CT slices and were therefore only able
to measure airways oriented perpendicular to this plane
[4–6, 8, 9, 11]. This is an important limitation as it mark-
edly limits the number of airways that can be measured.
Further, some studies measured AWT manually [5, 9, 11],
which is less accurate than automated measurements
and more susceptible to interobserver variation [12].
Advances in multi-detector CT scanners, development
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of multiplanar, three-dimensional segmentation of air-
ways and automated measurements of airway walls now
make it possible to measure AWT in multiple airways
throughout the bronchial tree.
Finally, most previous studies included selective popula-
tions of older subjects and often only current- or ex-
smokers [13–15]. For this reason, the effects of age and
smoking status on AWT are largely unknown. This may
be important, since both age and smoking status are likely
to affect AWT. Aging has been shown to play a role in re-
modeling and repair processes in lung parenchyma and
similar processes are likely to occur in the airway walls as
well [16, 17]. Additionally, smoking is the main risk factor
for the development of COPD. It causes airway inflamma-
tion and remodeling, both influencing AWT [18–20].
In the present study, we investigated AWT in a group
of well characterized healthy subjects. An automated
software program was used, measuring a large number
of airways perpendicular to the airway direction through-
out the lungs. The objectives of this study were to investi-
gate if age, gender and smoking are associated with AWT
and whether a higher AWT is associated with lower levels
of pulmonary function in healthy current- and never-
smokers with a wide age range.
Methods
Study population
In this study, healthy never- and current-smokers were
included if they met the following criteria: normal spirom-
etry, no bronchial hyperresponsiveness to methacholine
and normal pulmonary health according to the physician.
Spirometry was considered to be normal if the forced
expiratory volume in 1 s (FEV1) was ≥80%predicted, the
FEV1/forced vital capacity (FVC) was greater than the
lower limit of normal and reversibility to salbutamol was
<10% of the predicted value. Never-smokers were defined
as subjects who had not smoked during the last year, had
never smoked for as long as 1 year, and had not smoked
more than 0.5 packyears. The study was approved by the
local medical ethics committee (METc 2007/007) and all
subjects gave their written informed consent.
High Resolution CT scans and airway measurements
High resolution CT (HRCT) scans were performed using
a 64-multidetector CT scanner (Somatom Definition,
Siemens, Forchheim, Germany). Scans were performed at
full inspiration. Scanning was performed with 20 mAs. The
kV setting was determined by weight: 100 kV for subjects
<60 kg, 120 kV for subjects ≥60 and <80 kg and 140 kV for
subjects >80 kg. Acquired imaging data were reconstructed
using a standard soft kernel (B30f), with 1.0 mm slice
thickness and 0.7 mm increment. The CT radiation dose
was approximately 0.8 mSv (100 kV) to 1.5 mSv (140 kV),
the (median CT radiation dose was 0.95 mSv.
Airway measurements were performed with the auto-
mated software program MeVis Airway Examiner 1.0
(Fraunhofer Institute for Medical Image Computing
MEVIS, Bremen, Germany). The software automatically
extracts airway centerlines, re-samples images perpen-
dicular to the airway direction and detects inner and
outer airway wall borders in these images (Fig. 1) [21].
The outer wall border is detectable when no adjacent
tissue with similar CT density is present. All HRCT
scans were visually evaluated for appropriate segmenta-
tion and data from lobes that were incorrectly seg-
mented were removed from further analyses. The
software calculated AWT, airway wall area percentage
(%AWA), i.e. airway wall area/total airway area *100,
and the fraction of the airway that was detectable
(assessed perimeter fraction, APF) for each location
and reported the average AWT and %AWA per lung
lobe for airways with predefined external diameters
(3.5 mm, 4 mm, 4.5 mm, 5 mm, 6 mm, 8 mm and
10 mm, all ±0.25 mm) from all the separately measured
airway locations. The software also reported the cumu-
lative APF per lung lobe for each external diameter
measured, i.e. the total number of airway perimeters
measured, calculated by adding up the APF of all mea-
sured airways with the appropriate external diameter. A
higher cumulative APF reflects a higher number of
sampling points assessed. The mean AWT and %AWA
per lung for each external diameter were calculated as
the weighted average of the AWT and %AWA per lobe,
with the cumulative APF per lobe as the weighting fac-
tor. As an overall measurement of AWT, the AWT at
an internal perimeter of 10 mm (AWT Pi10) was esti-
mated based on all measurements at the 7 different di-
ameters, similar to the method of Grydeland et al. [13].
The AWT Pi10 was calculated by plotting the square
root of the average area of airway wall per lobe against
the internal perimeter of these measurements. The
resulting regression line was used to calculate the AWT
Pi10. Our method differed slightly from the Grydeland
et al. in that they used all measured airways, instead of
airways with predefined diameters [13].
Pulmonary function tests
Spirometry was performed before and after 400 μg salbu-
tamol according to current ATS/ERS guidelines [22, 23].
Impulse oscillometry (IOS) was performed to measure re-
sistance at 5 Hz (R5), resistance at 20 Hz (R20), the differ-
ence between R5 and R20 (R5-20) and reactance at 5 Hz
(X5). Body plethysmography was performed to measure
functional residual capacity (FRC), total lung capacity
(TLC) and residual volume (RV). The diffusion capacity of
the lung for carbon monoxide corrected for hemoglobin
level (TLCOc) and TLCOc corrected for the alveolar
volume (TLCOc/VA) were measured. Provocation tests
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were performed with methacholine (0.03 to 16 mg/ml),
using a 2-min tidal breathing method, adapted from
Cockcroft et al. [24].
Statistical analysis
Differences in AWT Pi10, AWT and %AWA were tested
with Student’s t-test or analysis of variance (ANOVA),
with post-hoc Holm’s Bonferroni correction for multiple
testing. To assess the effect of age on airway wall thick-
ness, linear regressions were performed with either
AWT Pi10, AWT or %AWA as the outcome variable
and age, gender and smoking status as predictor vari-
ables. To assess the effect of airway wall thickness on
pulmonary function parameters, multivariate regression
analyses with the pulmonary function parameter as out-
come variable and AWT Pi10 as predictor variable with
adjustment for age, gender and smoking status were per-
formed. If height is part of the formula to calculate the
predicted value of a pulmonary function parameter,
height was also adjusted for. Similar analyses were per-
formed with the AWT and %AWA transformed to the
number of standard deviations (SD) from the mean at the
different diameters. All statistical analyses were performed
with IBM SPSS version 20 (IBM, Armonk, NY, USA).
P-values <0.05 were considered statistically significant.
Results
A total of 99 subjects were included. Their baseline charac-
teristics are presented in Table 1. In 25 patients the soft-
ware was not able to detect the airways correctly in the
entire lung and the data from lobes that were incorrectly
segmented were removed from further analyses. Data from
one lobe was removed from the analysis for 21 patients
and data from two lobes was removed in 4 patients. The
median cumulative assessed perimeter fractions (APF) per
patient and per lung lobe are presented in Additional file 1:
Table S1. The median cumulative APF per patient was 146
airways, reflecting that the AWT was measured on a total
146 airway perimeters. The cumulative APF was highest
for airways with 5 mm external diameter. At this diameter
the software measured a median of 55 airway perimeters.
The software was able to measure wall thickness of all sub-
jects between 4.5 and 6 mm. At smaller diameters there
were less successful measurements (96 of 99 subjects at
4 mm and 58 of 99 subjects at 3.5 mm). Furthermore the
number of airways measured became very limited at
3.5 mm with a cumulative APF of only 0.77 airways. Below
3.5 mm no airways were detected by the software. At
higher diameters the APF also decreased to 1.31 airways at
10 mm. The lowest cumulative APF was observed in the
right middle lobe, reflecting the smaller size of this lobe.
Fig. 1 Airway wall thickness analysis. a The airway wall tree as extracted by the software program. The airway highlighted in yellow is stretched
to a 2D picture in (b). The grey square corresponds to the purple vertical line in (b). This is a cross sectional image of the airway oriented
perpendicular to the local centerline direction and given in more detail in (c). The red line is the outer airway wall perimeter and the yellow
line is the inner airway wall perimeter. Airway wall thickness (AWT) and wall area percentage (%AWA) are measured in areas of the continuous
red line. Dashed parts of the outer perimeter are interpolated and not used for measurements. The assessed perimeter fraction (APF) is the
fraction of the outer perimeter that has a continuous line
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AWT and %AWA at different diameters and in
different lobes
AWT increased linearly with increasing diameter from
0.30 mm to 3.5 mm external diameter to 1.42 mm at
10 mm (Additional file 2: Figure S1a). The %AWA
was 29.8% at 3.5 mm external diameter and increased
to 45.1% at 6 mm after this the %AWA reached a plat-
eau around 48% (Additional file 2: Figure S1b). The
AWT and %AWA were comparable in all lobes for
external diameters between 4 and 10 mm (Additional
file 2: Figure S1c and d and Additional file 1: Tables
S2 and S3). At 3.5 mm the AWT and %AWA were sig-
nificantly higher in the left lower lobe than in the
right upper lobe.
Effect of age, gender and smoking status on AWT Pi10,
AWT and %AWA
Higher age was associated with lower AWT, assessed
by the overall measure of airway wall thickness, the
AWT Pi10 (b = −0.003, p < 0.001, Fig. 2). A trend was
found towards a lower AWT Pi10 in men compared to
women (mean (SD) 0.45 (0.10) mm versus 0.48 (0.09)
mm respectively, p = 0.088). AWT Pi10 was signifi-
cantly higher in current- than in never-smokers (mean
(SD) 0.49 (0.09) mm and 0.44 (0.10) mm respectively,
p = 0.022, Fig. 3). AWT and %AWT were also higher in
current- than never-smokers at 4 mm, 4.5 mm, 5 mm,
Fig. 2 Association between AWT Pi10 and age. b = −0.003, p < 0.001;
AWT Pi10 = airway wall thickness at an internal perimeter of 10 mm
estimated from all measurements
Fig. 3 AWT Pi10 in never- and current-smokers. AWT Pi10 = airway
wall thickness at an internal perimeter of 10 mm estimated from
all measurements
Table 1 Baseline characteristics of the 99 subjects
Age (years) 39 (22 – 54)
Males (n, %) 56 (57)
Current-smokers (n, %) 51 (52)
Cigarettes/day (n)a 15 (3 – 29)
Packyears (n)a 15 (10 – 20)
FEV1 (%predicted) 105 (98 – 113)
FVC (%predicted) 113 (105 – 118)
FEV1/FVC (%) 79 (76 – 84)
FEF25–75 (%predicted) 83 (71 – 99)
RV/TLC (%predicted) 86 (77 – 96)
TLCOc/VA (%predicted) 96 (88 – 104)
R5 (kPa/L/s) 0.30 (0.25 – 0.36)
R20 (kPa/L/s) 0.28 (0.22 – 0.33)
R5-20 (kPa/L/s) 0.02 (0.00 – 0.05)
X5 (kPa/L/s) −0.07 (−0.10 – −0.06)
Values are presented as medians with interquartile ranges unless
stated otherwise
FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, FEF25–75
forced expiratory flow between 25 and 75% of FVC, RV/TLC residual
volume/total lung capacity, TLCOc diffusion capacity of the lung for
carbon monoxide, corrected for hemoglobin level, VA alveolar volume,
R5 resistance at 5 Hz, R20 resistance at 20Hz, R5-20 difference between
R5 and R20, X5 reactance at 5 Hz, AX reactance area
aonly in current-smokers
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6 mm and 8 mm diameter, but not at 3.5 mm and
10 mm (Additional file 1: Tables S4 and S5). In multi-
variate linear regression analysis, both age and smoking
status were significantly and independently associated
with the AWT Pi10. AWT Pi10 was lower at higher age
(b = −0.002, p < 0.001) and higher in current-smokers
(b = 0.041, p = 0.021). Gender was not independently
associated with AWT Pi10 (b = 0.011, p = 0.552). No
significant interaction between age and smoking status
was found (p = 0.45). In similar analyses, age was nega-
tively associated with AWT and %AWA for all pre-
defined diameters, except for 10 mm and current-smok-
ing was associated with a higher AWT and %AWA at
4.5 mm, 5 mm and 6 mm diameter (Additional file 1:
Tables S6 and S7).
Association between airway wall thickness and
pulmonary function
A higher AWT Pi10 was associated with lower FEV1,
FEF25–75, FVC, FEV1/FVC and X5 and higher R5 and
R20, independently from age, gender, height and smok-
ing status (Table 2). AWT Pi10 was not associated with
RV/TLC or R5-20. Additionally, a higher AWT Pi10
was associated with higher TLCOc/VA. Similar associa-
tions were seen for AWT and %AWA at the different
airway diameters (Additional file 1: Tables S8 and S9).
The regression coefficients, representing the change in
a pulmonary function test for every standard deviation
change in AWT or %AWA, were very similar for the
different diameters.
Discussion
The present study demonstrates that airway wall thick-
ness (AWT) decreases with aging and is higher in
current- than never-smokers. In addition, we show that
thicker airway walls are associated with lower levels of
pulmonary function.
The effect of age on AWT has been previously de-
scribed by Grydeland et al. in COPD patients and
healthy smokers >40 years [13]. In this study, the esti-
mated AWT at an internal perimeter of 10 mm (AWT
Pi10) decreased with 0.003 mm per year in the healthy
smokers, which is very similar to the results of this study
(0.002 mm per year in the multivariate analysis). These
findings are partly in agreement with a study by Zach et
al. [14]. In this study, age did not contribute to AWT
Pi10 in 92 healthy subjects >45 years. However, a higher
age was associated with a lower %AWA. We extend the
data of Zach et al. by also including younger subjects and
never-smokers. This way, we were able to show that air-
way walls become thinner from early adulthood on
throughout life and that this process is independent from
smoking. On the other hand, in a study by Matsuoka et al.
no differences were found in the ratio of airway wall thick-
ness and the total diameter of the bronchus in healthy
subjects aged 21–40, 41–65 and >65 years old [11]. How-
ever in this study, only transverse CT slices were used,
thereby limiting the number of airways measured. Fur-
thermore, the airways were measured manually, which is
less accurate than automated measurements and more
susceptible to interobserver variation [12].
Aging has profound influences on the lung. The elastic
recoil of the lung decreases significantly with aging,
mainly due to alveolar enlargement without alveolar wall
destruction, a condition that is also called ‘senile lung’
[16]. It has been suggested that remodeling of the extra-
cellular matrix (ECM) in the lung parenchyma, with deg-
radation of elastin and collagens, is the main factor in
this aging process [16, 17]. However, there is limited
knowledge of the effects of aging on changes in the air-
way walls. Animal studies suggest that aging of Clara
cells, the progenitor cells of the airway epithelium, may
impair airway regeneration, which could lead to thinning
of the airway walls [25]. It is also possible that, similar to
the parenchyma, ECM proteins are degraded in the airway
walls with aging. ECM proteins also degrade with age in
many other structures in the human body, for instance
the skin [26]. Interestingly, in the aging skin, an altered
function of fibroblasts has been observed, resulting in a
decreased production of collagen and increased produc-
tion of collagen-degrading matrix metalloproteinases. It is
tempting to speculate that comparable changes may occur
in aging airway fibroblasts. Alternatively, inflammatory
cells and other residential cells, like epithelial and smooth
muscle cells, may have similar effects.




FEV1 (L) −1.697 0.001
FEF25–75 (L/s) −3.215 0.001
FVC (L) −1.288 0.047
FEV1/FVC (%) −13.358 0.018
RV/TLC (%) 3.202 0.468
TLCOc/VA (mmol/min/kPa/L) 0.431 0.029
R5 (kPa/L/s) 0.363 <0.001
R20 (kPa/L/s) 0.288 <0.001
R5-20 (kPa/L/s) 0.075 0.164
X5 (kPa/L/s) −0.080 0.028
Linear regressions with pulmonary function parameters as outcome and
airway wall thickness as predictor variable and age, gender, smoking status
and height added as covariates
AWT Pi10 airway wall thickness at an internal perimeter of 10 mm estimated
from all measurements, FEV1 forced expiratory volume in 1 s, FVC forced vital
capacity, FEF25–75 forced expiratory flow between 25 and 75% of FVC, RV/TLC
residual volume/total lung capacity, TLCOc diffusion capacity of the lung for
carbon monoxide, corrected for hemoglobin level, VA alveolar volume, R5
resistance at 5 Hz, R20 resistance at 20Hz, R5-20 difference between R5 and
R20, X5 reactance at 5 Hz
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This study demonstrates that current-smokers have a
higher AWT than never-smokers, independently from
age. Donohue et al. did not find higher thickness of airway
walls in current-smokers than in never- or ex-smokers in
a large cohort of ex-, current- and never-smokers [15].
However, they did show that airway walls were thicker
with more cigarette exposure, i.e. more packyears smoked
and that current-smoking was associated with a narrower
airway lumen. In the study by Matsuoka et al. the in the
ratio of airway wall thickness and the total diameter of the
bronchus was higher in smokers aged >65 than never-
smokers aged >65. No differences were seen between
smokers and never-smokers <65 years [11]. Thicker air-
way walls in current-smokers may be due to the effects of
continuous smoke exposure on the epithelium, causing
the epithelium to produce pro-inflammatory cytokines
that induce remodeling [18–20]. In line with this, a study
in 25 smokers and 14 non-smokers showed more goblet
cell metaplasia, more smooth muscle hypertrophy and
more inflammation in the walls of airways in current-
smokers [27]. Thus, smoking may affect AWT in several
different ways. It is not possible to distinguish between the
different causes of airway wall thickening on HRCT scans.
An increase in AWT may be of clinical relevance, since it
is associated with lower levels of pulmonary function, inde-
pendent of age, gender, height and smoking status. Correla-
tions between pulmonary function and wall thickness have
previously been demonstrated in studies with COPD
patients and older healthy controls [3, 5–9]. In this study,
associations between AWT and pulmonary function are
demonstrated in a population of subjects who were specif-
ically selected to be asymptomatic and have normal spir-
ometry. Interestingly, AWT was associated not only with
large airway parameters like the FEV1, FVC and FEV1/FVC,
but also with small airway parameters like the FEF25–75 and
X5. This is remarkable since the small airways have an in-
ternal diameter <2 mm and are therefore too small to be
measured on HRCT scans at the moment. Additionally, an
increase of 1 SD in AWT in airways with smaller diameters
(e.g. 4 or 4.5 mm) or larger diameters (e.g. 6 or 8 mm) had
similar effects on pulmonary function tests measuring large
and small airways (Additional file 1: Tables S8 and S9).
These results suggest that thickening of airway walls in
current-smokers occurs not only in the airways that were
measured, but throughout the lungs. Advances in ultra-
high resolution imaging, like cone beam CT imaging, may
provide more information about the AWT in the small
airways in the future [28, 29]. Unexpectedly, thicker air-
way walls were associated with a higher TLCOc/VA. As it
is unlikely that subjects with thicker airway walls truly
have a higher diffusion capacity, we hypothesize that the
increased diffusion capacity in subjects with thicker airway
walls most likely results from underestimation of the al-
veolar volume due to ventilation inhomogeneity [30].
There are several strengths to our study. First, we used a
software program automatically detecting the bronchial tree
and measuring AWT perpendicular to the airway direction.
Using this method, we were able to measure a median of
146 airway perimeters (combined from partial airway pe-
rimeters) per patient. These measurements were performed
at different airway diameters, ranging from 3.5 to 10 mm
external diameter, in all lung lobes. Second, all HRCT scans
were performed in the same center, using the same acquisi-
tion device settings. Finally, all subjects were extensively
characterized with pulmonary function tests, smoking and
medical history. There are also limitations to this study. As
AWT was measured at pre-defined external airway parame-
ters, it is not possible to determine if increases in AWT are
due to actual thickening of the wall or due to reduction in
the luminal diameter. This is a general problem with meas-
uring AWT. A possible solution could be to assess airways
per generation. However, currently, it is still difficult to do
this and labeling of airway generation is prone to error.
Conclusions
In conclusion, airway wall thickness measured with HRCT
scans is a feasible technique to investigate anatomical
changes of the airways. We showed that airway wall thick-
ness decreases with age, possibly reflecting structural
changes of the airways during aging. Additionally, current-
smokers have thicker airway walls than never-smokers,
and this increased airway wall thickness is associated with
lower levels of pulmonary function.
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